Skip to main content
      #1456
      💥In a real-world UK PsA cohort, 25% had joint erosion @ diagnosis

      ➡️Mean disease duration 34mo. @ diagnos

      Caoilfhionn Connolly CaoilfhionnMD

      9 months 3 weeks ago
      #1456 💥In a real-world UK PsA cohort, 25% had joint erosion @ diagnosis ➡️Mean disease duration 34mo. @ diagnosis ➡️Mean disability score = mod. to severe 💥Delay in diagnosis=poor outcomes ‼️Are we doing enough to catch PsA early? ? 🔑Earlier detection key #ACR @RheumNow
      #1375🏋️‍♀️ Strength Training in RA

      ➡️ 12-week trial 28 ♀️
      High-intensity(HIRT) v. Low-intensity+blo

      Caoilfhionn Connolly CaoilfhionnMD

      9 months 3 weeks ago
      #1375🏋️‍♀️ Strength Training in RA ➡️ 12-week trial 28 ♀️ High-intensity(HIRT) v. Low-intensity+blood flow restriction(LIT-BFR) 🔴Equivalent gains:Lat-pulldown, biceps curl 🔴Knee extension:HIRT>LIT-BFR (non-significant) ✅ LIT-BFR: Alternative for RA sarcopenia #ACR24 @RheumNow
      John Stone
      Steroid-free AAV
      CYCLOPS: steroid tox like “wallpaper on room”
      WGET (ETN for GCA) - taper off by 6 mos -

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      John Stone Steroid-free AAV CYCLOPS: steroid tox like “wallpaper on room” WGET (ETN for GCA) - taper off by 6 mos - neg trial but started tapers RAVE - low doses 8-9 mg/d over 18 mos LoVAS - low dose steroid equally eff ADVOCATE - AVA one month taper, tox score #ACR24 @RheumNow https://t.co/C7eLK5UNPM
      It's always so dispiriting to see PMR patients rack up steroid side effects in front of your eyes.

      (the intense motivat

      David Liew drdavidliew

      9 months 3 weeks ago
      It's always so dispiriting to see PMR patients rack up steroid side effects in front of your eyes. (the intense motivation to do better than pred for our PMR patients) #ACR24 @SattuiSEMD @RADoctor ABST0975 @RheumNow https://t.co/FTsvrTIt2F
      #1474
      🔬Severe PsA? Guselkumab (GUS) has promise!

      ➡️In bionaive pts with severe disease activity,
      GUS v. PBO res

      Caoilfhionn Connolly CaoilfhionnMD

      9 months 3 weeks ago
      #1474 🔬Severe PsA? Guselkumab (GUS) has promise! ➡️In bionaive pts with severe disease activity, GUS v. PBO resulted in: 🔴73% improvement in joints 🔴53% lower disease activity 🔴63% better PtGA by 2 years ➡️Rapid results by W2, sustained through W100. #ACR @RheumNow
      Nine out of ten adults in the USA struggle to understand basic health-related information. Across the pond, in the UK, 7.1 million adults read at, or below, the level of a nine-year-old, with 60% unable to understand health information. An increasing body of research in rheumatic diseases has sought to understand the impact of health literacy, long neglected as a social determinant of health, on clinical and non-clinical outcomes. Several
      Is participation in RISE assoc with improved quality of care?

      ➡️Enrolment assoc w ⬆️performance in several qual

      Mrinalini Dey DrMiniDey

      9 months 3 weeks ago
      Is participation in RISE assoc with improved quality of care? ➡️Enrolment assoc w ⬆️performance in several quality measures ➡️Most marked in practices with lower baseline performance ⏩Registry participation has potential to improve quality of rheum care Ab1644 #ACR24 @RheumNow
      Biosimilar changes
      ASP outpacing reimbursement making not affordable to use
      Working with CMS but needs further legislati

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      Biosimilar changes ASP outpacing reimbursement making not affordable to use Working with CMS but needs further legislation to fix this FDA may change interchangeability status for medications to no longer require switching studies @ACRheumDC @RheumNow #ACR24 https://t.co/daYQJvsHRG
      What’s on tap for Trump health care agenda?
      Uncertainty as to what priorities and actions will be
      ACR has plans to add

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      What’s on tap for Trump health care agenda? Uncertainty as to what priorities and actions will be ACR has plans to address legislative, regulatory, and state affairs @ACRheumDC #ACR24 @RheumNow https://t.co/a5z4RIOjRC
      A meta-analysis of 11 randomized trials shows no significant difference in efficacy of bDMARDs for early vs. established

      Antoni Chan MD (Prof) synovialjoints

      9 months 3 weeks ago
      A meta-analysis of 11 randomized trials shows no significant difference in efficacy of bDMARDs for early vs. established axial spondyloarthritis (axSpA). Treating at different stages yields comparable short-term outcomes. Abstr#1468 #Spondyloarthritis #RheumatologyResearch… https://t.co/QYuTcVj2m1 https://t.co/ADzEEbCvUM
      @ACRheumDC State Update:

      No changes at executive level
      Some shifts in state legislation

      With political changes and new

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      @ACRheumDC State Update: No changes at executive level Some shifts in state legislation With political changes and new administration, states will probably take larger role in healthcare legislation - PBM reform, copay accum, prior auth/step, reprod healthcare @RheumNow #ACR24 https://t.co/jc77HCLxqQ
      State Update @ACRheumDC
      No executive level changes, some state legislative flips

      Political changes will likely lead to

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      State Update @ACRheumDC No executive level changes, some state legislative flips Political changes will likely lead to more state legislative healthcare legislation - In the works for PBM reform, copay accum, prior auth/Step, reprod healthcare @RheumNow #ACR24 https://t.co/94KyHU0Blr
      #1326
      🔬 Predicting Imminent Inflammatory Arthritis

      ➡️543 anti-CCP+ at-risk (high/low) tracked

      🔑Predictors fo

      Caoilfhionn Connolly CaoilfhionnMD

      9 months 3 weeks ago
      #1326 🔬 Predicting Imminent Inflammatory Arthritis ➡️543 anti-CCP+ at-risk (high/low) tracked 🔑Predictors for IA in high-risk: 🔴EMS≥30min(OR 11) 🔴RF+(OR 6) 🔴US PD(OR 5) 🔴smJTC (OR 5) 🔑Predictors for IA in low risk: 🔴RF+(OR 8) 🔴Anti CCP >3xULN(OR 7) #ACR24 @RheumNow https://t.co/ou9HNcNb8X
      Dietary changes are intermittent fasting are common in axial spondylarthritis (axSpA) patients, possibly reducing inflam

      Antoni Chan MD (Prof) synovialjoints

      9 months 3 weeks ago
      Dietary changes are intermittent fasting are common in axial spondylarthritis (axSpA) patients, possibly reducing inflammation. A study found 55% currently on a diet and 31% fasting. Many believe these practices improve disease activity. Abstr#1459 #diet #axSpA @RheumNow #ACR24
      ×